| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 278.377 | 311.245 | 343.913 | 467.621 | 500.956 | 589.470 | 608.092 | 666.418 | 676.811 | 700.428 |
| Total Income - EUR | 278.397 | 312.681 | 344.667 | 467.805 | 501.136 | 589.482 | 608.111 | 667.422 | 678.373 | 722.417 |
| Total Expenses - EUR | 209.707 | 226.601 | 254.126 | 332.333 | 372.735 | 411.360 | 433.233 | 459.694 | 457.082 | 500.316 |
| Gross Profit/Loss - EUR | 68.690 | 86.079 | 90.542 | 135.472 | 128.401 | 178.122 | 174.878 | 207.727 | 221.291 | 222.101 |
| Net Profit/Loss - EUR | 56.985 | 72.222 | 85.890 | 130.794 | 123.390 | 172.852 | 168.918 | 201.057 | 208.366 | 184.372 |
| Employees | 7 | 7 | 6 | 7 | 8 | 9 | 9 | 9 | 9 | 9 |
Check the financial reports for the company - Dali Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16.422 | 18.870 | 55.825 | 48.202 | 73.619 | 56.086 | 45.298 | 29.806 | 38.925 | 95.167 |
| Current Assets | 49.072 | 64.217 | 78.934 | 125.040 | 92.245 | 143.779 | 148.481 | 195.494 | 213.843 | 173.779 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 900 | 0 | 0 | 0 | 0 |
| Receivables | 1.003 | 992 | 1.737 | 3.376 | 255 | 4.030 | 3.453 | 126.276 | 152.316 | 92.588 |
| Cash | 48.069 | 63.225 | 77.197 | 121.664 | 91.990 | 138.849 | 145.028 | 69.217 | 61.527 | 81.191 |
| Shareholders Funds | 57.897 | 73.124 | 86.777 | 131.665 | 124.244 | 173.689 | 169.738 | 201.879 | 209.185 | 185.187 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.598 | 9.963 | 47.981 | 41.577 | 41.621 | 26.175 | 24.041 | 23.420 | 43.583 | 83.758 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dali Medical Srl